Antibodies against interleukin-10 receptor reduce IL-6 and TNF-α levels and increase TGF‐β levels in patients with severe fever with thrombocytopenia syndrome virus and SARS-CoV-2 infection - Poll - MDSpire

Antibodies against interleukin-10 receptor reduce IL-6 and TNF-α levels and increase TGF‐β levels in patients with severe fever with thrombocytopenia syndrome virus and SARS-CoV-2 infection

  • By

  • Su Yeon Kang

  • Jeong Rae Yoo

  • EunJin Bae

  • Joowan Kim

  • Yejin Park

  • Misun Kim

  • Miyeon Kim

  • Hyo-Jin Ro

  • Daehee Hwang

  • Jeong-Yeon Lee

  • Dongcharn Cho

  • Huy Chau Nguyen

  • Hoai Jaclyn Hallam

  • Sang Taek Heo

  • Nam-Hyuk Cho

  • Kyung-Mi Lee

  • Andrew G. Letizia

  • Keun Hwa Lee

  • June 25, 2026

  • 0 min

Share

Original Source(s)

Antibodies against interleukin-10 receptor reduce IL-6 and TNF-α levels and increase TGF‐β levels in patients with severe fever with thrombocytopenia syndrome virus and SARS-CoV-2 infection

  • by Su Yeon Kang, Jeong Rae Yoo, EunJin Bae, Joowan Kim, Yejin Park, Misun Kim, Miyeon Kim, Hyo-Jin Ro, Daehee Hwang, Jeong-Yeon Lee, Dongcharn Cho, Huy Chau Nguyen, Hoai Jaclyn Hallam, Sang Taek Heo, Nam-Hyuk Cho, Kyung-Mi Lee, Andrew G. Letizia, Keun Hwa Lee

  • June 25, 2026

Related Content

Beyond Functional Independence: Symptom Burden and Emotional Difficulties in Pediatric Long COVID — A Cross-Sectional Exploratory Study

Effectiveness of seasonal mRNA COVID-19 vaccination against post COVID-19 condition between July 2023 and September 2024 among adults aged ≥ 60 years in Germany: a population-based cohort study

Influenza Vaccination Trends Among Children and Adolescents, 2017-2023